| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Insulin Glargine | FAERS: 3 | US FAERS | |
| 2 | lamivudine, zidovudine drug combination | FAERS: 2 | OFFSIDES US FAERS | |
| 3 | Canagliflozin | FAERS: 1 | US FAERS | |
| 4 | Insulin degludec | FAERS: 1 | US FAERS | |
| 5 | Liraglutide | FAERS: 1 | US FAERS | |
| 6 | Pravastatin | FAERS: 1 | US FAERS | |
| 7 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 8 | insulin aspart, insulin aspart protamine drug combination 30:70 | FAERS: 1 | US FAERS | |
| 9 | Oxcarbazepine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.